Andreas Fellgiebel Selected Research

Andreas Fellgiebel Research Topics

Disease

18	Alzheimer Disease (Alzheimer's Disease) 02/2020 - 08/2004
10	Dementia (Dementias) 01/2021 - 01/2007
8	Cognitive Dysfunction 01/2021 - 08/2004
3	Fabry Disease (Fabry's Disease) 01/2019 - 04/2007
2	Atrophy 03/2017 - 02/2015
2	Stroke (Strokes) 01/2011 - 10/2005
2	Ataxia (Dyssynergia) 03/2004 - 10/2003
2	Korsakoff Syndrome (Wernicke-Korsakoff Syndrome) 03/2004 - 10/2003
1	Tauopathies 01/2021
1	Psychomotor Agitation (Akathisia) 01/2019
1	Ambulatory Care Sensitive Conditions 01/2019
1	Fatigue 01/2019
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 06/2018
1	Amyloidosis 01/2015
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2013
1	Major Depressive Disorder (Major Depressive Disorders) 12/2011
1	Temporal Lobe Epilepsy 03/2010
1	Seizures (Absence Seizure) 03/2010
1	Epilepsy (Aura) 03/2010
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2008
1	Frontotemporal Dementia (Semantic Dementia) 01/2007
1	Schizophrenia (Dementia Praecox) 05/2006
1	Coma (Comas) 10/2005
1	Wallerian Degeneration 08/2005
1	Alcoholic Korsakoff Syndrome 03/2004

Drug/Important Bio-Agent (IBA)

7	Amyloid (Amyloid Fibrils)IBA 01/2021 - 03/2009
6	Glucose (Dextrose)FDA LinkGeneric 09/2011 - 10/2003
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2004
4	Pharmaceutical PreparationsIBA 01/2019 - 01/2007
4	tau Proteins (tau Protein)IBA 02/2012 - 08/2004
3	Amyloid beta-PeptidesIBA 01/2019 - 08/2005
3	Biomarkers (Surrogate Marker)IBA 11/2014 - 02/2012
2	Dopamine (Intropin)FDA LinkGeneric 01/2020 - 03/2010
2	Metalloproteases (Metalloproteinases)IBA 01/2019 - 11/2014
2	RetinoidsIBA 01/2019 - 11/2014
2	Acitretin FDA Link 01/2019 - 11/2014
2	Cholinergic Agents (Cholinergics)IBA 03/2017 - 01/2014
2	pleiotrophin (HARP)IBA 02/2015 - 02/2015
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 11/2014 - 03/2009
2	Threonine (L-Threonine)FDA Link 03/2009 - 08/2004
1	CholesterolIBA 02/2020
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 02/2020
1	Bupropion (Wellbutrin)FDA LinkGeneric 01/2020
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2020
1	agalsidase beta FDA Link 01/2019
1	belimumabIBA 01/2019
1	AntibodiesIBA 01/2019
1	AutoantibodiesIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Donepezil (Aricept)FDA LinkGeneric 06/2015
1	EsterasesIBA 06/2015
1	Acetylcholine (Acetylcholine Chloride)FDA Link 06/2015
1	florbetapirIBA 01/2015
1	DisintegrinsIBA 11/2014
1	Apolipoproteins E (ApoE)IBA 05/2014
1	ApolipoproteinsIBA 05/2014
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2013
1	Cerebrospinal Fluid ProteinsIBA 02/2012
1	benzoylamido- 4'- aminostilbene- 2,2'- disulfonate (BADS)IBA 01/2011
1	Dopamine Receptors (Dopamine Receptor)IBA 03/2010
1	Pilocarpine (Ocusert)FDA LinkGeneric 03/2010
1	LigandsIBA 03/2010
1	fallyprideIBA 03/2010
1	EnzymesIBA 04/2007
1	Aripiprazole (Abilify)FDA Link 01/2007
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 05/2006
1	Free RadicalsIBA 08/2005
1	Thiamine (Aneurin)FDA Link 10/2003

Therapy/Procedure

4	Therapeutics 01/2021 - 04/2007
1	Music Therapy 01/2021
1	Ambulatory Care (Outpatient Care) 01/2019
1	Length of Stay 01/2019
1	Activities of Daily Living (ADL) 03/2017
1	Enzyme Replacement Therapy 01/2014
1	Occupational Therapy (Therapy, Occupational) 08/2011
1	Drug Therapy (Chemotherapy) 06/2008
1	Critical Care (Surgical Intensive Care) 10/2005